Literature DB >> 25627110

Palliative therapy for esophageal cancer: laser therapy alone is associated with a better functional outcome.

Anna Pozza1, Francesca R Erroi, Marco Scarpa, Lino Polese, Luigi Rampazzo, Lorenzo Norberto.   

Abstract

The aim of our study was to compare functional outcome and survival in patients who underwent laser therapy (LT) or laser therapy and esophageal stenting (LTES) to palliate inoperable esophageal cancer. Two hundred and twenty-seven consecutive patients who had endoscopic palliation for esophageal cancer were enrolled in this retrospective study. One hundred and sixty-four underwent LT alone and 63 had LTES. A dysphagia score was adopted (0: absolute dysphagia; 1: liquid diet; 2: semisolid diet; 3: free diet). Survival analysis and non parametric statistics were performed. Patients in the LTES group reported a significantly worse dysphagia score than LT patients (p < 0.01). LTES patients more frequently reported difficulty swallowing than LT patients (p < 0.01). No difference between LTES and LT groups was observed in terms of overall survival. Only radiotherapy resulted in a significant predictor of better survival (p = 0.007). Despite a similar survival, LTES is a predictor of a worse functional palliation than LT alone. Radiotherapy was associated with better survival in patients treated with LT. Therefore, these data seem to suggest that a combination of endoscopic LT and external radiotherapy may yield the best results in palliative care of advanced esophageal cancer.

Entities:  

Mesh:

Year:  2015        PMID: 25627110     DOI: 10.1007/s13304-015-0277-4

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  20 in total

1.  Palliation of inoperable esophageal carcinoma: a prospective randomized trial of laser therapy and stent placement.

Authors:  A Adam; J Ellul; A F Watkinson; B S Tan; R A Morgan; M P Saunders; R C Mason
Journal:  Radiology       Date:  1997-02       Impact factor: 11.105

Review 2.  Systematic review of health-related quality of life after esophagectomy for esophageal cancer.

Authors:  Marco Scarpa; Stefano Valente; Rita Alfieri; Matteo Cagol; Giorgio Diamantis; Ermanno Ancona; Carlo Castoro
Journal:  World J Gastroenterol       Date:  2011-11-14       Impact factor: 5.742

3.  Inoperable adenocarcinoma of the oesophagogastric junction: a comparative clinical study of laser coagulation versus self-expanding metallic stents with special reference to cost analysis.

Authors:  E I T Sihvo; T Pentikäinen; M E Luostarinen; O J Rämö; J A Salo
Journal:  Eur J Surg Oncol       Date:  2002-11       Impact factor: 4.424

4.  Laser augmented by brachytherapy versus laser alone in the palliation of adenocarcinoma of the oesophagus and cardia: a randomised study.

Authors:  G M Spencer; S M Thorpe; G M Blackman; J Solano; J S Tobias; L B Lovat; S G Bown
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

5.  Combination of laser treatment and intraluminal radiotherapy for malignant dysphagia.

Authors:  E Shmueli; E Srivastava; P J Dawes; M Clague; K Matthewson; C O Record
Journal:  Gut       Date:  1996-06       Impact factor: 23.059

Review 6.  WITHDRAWN: Interventions for dysphagia in oesophageal cancer.

Authors:  Aravamuthan Sreedharan; Keith Harris; Adrian Crellin; David Forman; Simon M Everett
Journal:  Cochrane Database Syst Rev       Date:  2011-02-16

7.  EsophaCoil: long-term results in 81 patients.

Authors:  D Wengrower; A Fiorini; J Valero; C Waldbaum; N Chopita; N Landoni; S Judchack; E Goldin
Journal:  Gastrointest Endosc       Date:  1998-10       Impact factor: 9.427

8.  A comparison of laser therapy, plastic stents, and expandable metal stents for palliation of malignant dysphagia in patients without a fistula.

Authors:  A M Gevers; E Macken; M Hiele; P Rutgeerts
Journal:  Gastrointest Endosc       Date:  1998-10       Impact factor: 9.427

9.  Palliative intubation of oesophagogastric neoplasms at fibreoptic endoscopy.

Authors:  A L Ogilvie; M W Dronfield; R Ferguson; M Atkinson
Journal:  Gut       Date:  1982-12       Impact factor: 23.059

10.  Cancer statistics, 2003.

Authors:  Ahmedin Jemal; Taylor Murray; Alicia Samuels; Asma Ghafoor; Elizabeth Ward; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2003 Jan-Feb       Impact factor: 508.702

View more
  1 in total

1.  p38 predicts depression and poor outcome in esophageal cancer.

Authors:  Yao Cheng; Zhe Qiao; Chengxue Dang; Bin Zhou; Shaomin Li; Wei Zhang; Jiantao Jiang; Yongchun Song; Jin Zhang; Dongmei Diao
Journal:  Oncol Lett       Date:  2017-10-03       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.